| Degree | Department/Program | Institute | Year |
| 1982 | |||
| 1988 | |||
| 1997 | |||
| 2003 | |||
| 2004 |
1. -, Supervisor: Dr. Eren Erken, Others, Others, Other Department, ADANA, Turkey, .
2. -, Supervisor: Dr. Eren Erken, Çukurova University, Others, Other Department, ADANA, Turkey, .
| Title | Institute | Year |
| - | - | 2015-06-03 - 2017-06-20 |
| Title | Dutie | Institution/Other | Year |
| - | - | - | 2015-06-03 - 2017-06-20 |
2014
20. Keskek, S.; Kirim, S.; Yanmaz, N.; Keskek, N.; Ortoglu, G.; Canataroglu, A. Direct medical cost of type 1 and type 2 diabetes in Turkey. INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2014, 34, 77-81. 400 + 5https://dx.doi.org/10.1007/s13410-013-0159-6
Times Cited: 1
2013
19. Sakalli, H.; Calikusu, Z.; Sariakcali, B.; Polat, A.; Canataroglu, A. URINARY N-ACETYL-BETA-D-GLUCOSAMINIDASE LEVELS IN CANCER PATIENTS TREATED WITH CISPLATIN. NOBEL MEDICUS, 2013, 9, 56-60. 500 + 5
Times Cited: 1
2012
18. Bagir, G.; Oksuz, M.; Dogan, U.; Egesel, T.; Canataroglu, A. Relationship Between Hemochromatosis Gene Mutations and Degree of Fibrosis in Liver Disease Associated with Chronic Hepatitis B and C. TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2012, 32, 917-924. 500 + 0
17. Guvenc, B.; Canataroglu, A.; Unsal, C.; Yildiz, S.; Turhan, F.; Bozdogan, S.; Dincer, S.; Erkman, H. beta-Thalassemia mutations and hemoglobinopathies in Adana, Turkey: results from a single center study. ARCHIVES OF MEDICAL SCIENCE, 2012, 8, 411-414. 650 + 60
Times Cited: 12
16. Guvenc, B.; Canataroglu, A.; Unsal, C.; Yildiz, S.; Turhan, F.; Bozdogan, S.; Dincer, S.; Erkman, H. beta-Globin chain abnormalities with coexisting alpha-thalassemia mutations. ARCHIVES OF MEDICAL SCIENCE, 2012, 8, 644-649. 650 + 20
Times Cited: 4
2011
15. Erdogan, M.; Canataroglu, A.; Ganidagli, S.; Kulaksizoglu, M. Metabolic syndrome prevalence in subclinic and overt hypothyroid patients and the relation among metabolic syndrome parameters. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2011, 34, 488-492. 850 + 85
Times Cited: 17
2010
14. Erdogan, M.; Solmaz, S.; Canataroglu, A.; Kulaksizoglu, M.; Cetinkalp, S.; Ozgen, A.; Saygili, F.; Yilmaz, C. Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in diabetic foot ulcers. ENDOCRINE, 2010, 37, 449-454. 550 + 15
Times Cited: 3
2005
13. Canataroglu, H.; Varinli, I.; Ozcan, A.; Canataroglu, A.; Doran, F.; Varinli, S. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy. OCULAR IMMUNOLOGY AND INFLAMMATION, 2005, 13, 375-381. 550 + 225
Times Cited: 45
2004
12. Guvenc, B.; Unsal, C.; Gurkan, E.; Canataroglu, A.; Saritas, B.; Evran, M. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report. TRANSFUSION AND APHERESIS SCIENCE, 2004, 31, 17-20. 550 + 30
Times Cited: 6
2003
11. Kozanoglu, E.; Canataroglu, A.; Abayli, B.; Colakoglu, S.; Goncu, K. Fibromyalgia syndrome in patients with hepatitis C infection. RHEUMATOLOGY INTERNATIONAL, 2003, 23, 248-251. 800 + 180
Times Cited: 36
10. Sert, M.; Tetiker, T.; Kirim, S.; Soyupak, S.; Canataroglu, A.; Kocak, M. Type 2 diabetes mellitus and osteopenia: is there an association?. ACTA DIABETOLOGICA, 2003, 40, 105-108. 450 + 75
Times Cited: 15
9. Canataroglu, A.; Gumurdulu, Y.; Gumurdulu, D.; Balal, M.; Tuncer, I.; Sagliker, Y. Coexistence of cystic intra-abdominal lymphangiomas and diffuse venous haemangiomas in adult life. NETHERLANDS JOURNAL OF MEDICINE, 2003, 61, 95-97. 850 + 15
Times Cited: 3
8. Canataroglu, A.; Tanriverdi, K.; ınal, T.; Seydaoglu, G.; Arslan, D.; Ozbek, S.; Baslamisli, F. Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Behcet's disease. RHEUMATOLOGY INTERNATIONAL, 2003, 23, 236-240. 800 + 110
Times Cited: 22
7. Gumurdulu, Y.; Yapar, Z.; Canataroglu, A.; Serin, E.; Gumurdulu, D.; Kibar, M.; Colakoglu, S. Gastric emptying time and the effect of cisapride in cirrhotic patients with autonomic neuropathy. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 36, 175-178. 600 + 35
Times Cited: 7
2002
6. Soy, M.; Ozer, H.; Canataroglu, A.; Gumurdulu, D.; Erken, E. Vasculitis induced by zafirlukast therapy. CLINICAL RHEUMATOLOGY, 2002, 21, 328-329. 700 + 40
Times Cited: 8
2001
5. Aikimbaev, K.; Guvenc, B.; Canataroglu, A.; Canataroglu, H.; Baslamisli, F.; Oguz, M. Value of duplex and color Doppler ultrasonography in the evaluation of orbital vascular flow and resistance in sickle cell disease. AMERICAN JOURNAL OF HEMATOLOGY, 2001, 67, 163-167. 650 + 65
Times Cited: 13
4. Aikimbaev, K.; Canataroglu, A.; Ozbek, S.; Usal, A. Renal vascular resistance in progressive systemic sclerosis: Evaluation with duplex Doppler ultrasound. ANGIOLOGY, 2001, 52, 697-701. 850 + 75
Times Cited: 15
3. Guvenc, B.; Canataroglu, A.; Gumurdulu, Y.; Gumudulu, D.; Paydas, S. Multiple myeloma with skin involvement. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2001, 15, 328-329. 800 + 25
Times Cited: 5
1997
2. Saltoglu, N.; Aksu, H.; Tasova, Y.; Arslan, A.; Canataroglu, A.; Dundar, I.; Koksal, F. Leptospirosis: Twelve Turkish patients with the Weil syndrome. ACTA MEDICA OKAYAMA, 1997, 51, 339-342. 400 + 20
Times Cited: 4
1994
1. Erkısı, M.; Drna, F.; Canataroglu, A.; Burgut, R. A TRIAL OF 2 FLUOROURACIL CONTAINING ADJUVANT CHEMOTHERAPY REGIMENS IN THE TREATMENT OF THE PATIENTS WITH COLORECTAL CANCER. PROCEEDINGS OF THE XVI INTERNATIONAL CANCER CONGRESS - FREE PAPERS AND POSTERS, TOMES 1-4, 1994, 1903-1908. 750 + 0
2. Can ŞEN , , Others, Others, Continue. 0
1. Ejder KÜÇÜKALTUN , , Others, Others, Continue. 0
10. Sencer GANİDAĞLI, , Others, Others, Continue. 0
9. Aybüke Ünsal KÖSENLİ , , Others, Others, Continue. 0
8. Soner SOLMAZ , , Others, Others, Continue. 0
7. Müge Eylem ŞENGÜL , , Others, Others, Continue. 0
6. Gülhan CAVLAK , , Others, Others, Continue. 0
5. Gülay ŞİMŞEK BAĞIR , , Others, Others, Continue. 0
4. Özden ÖZTÜRK ÇÖÇEN, -, Others, Others, Continue. 0
3. Siraç ÜRE , , Others, Others, Continue. 0
2. Tarık ÇALIŞKAN , , Others, Others, Continue. 0
1. Turgay YILMAZ , , Others, Others, Continue. 0
| Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
| Year | İH601 | Internal Medicine | Faculty of Medicine | Medicine | 1-1-2 |
| Year | İH601 | Internal Medicine | Faculty of Medicine | Medicine | 1-1-2 |
| Year | İH601 | Internal Medicine | Faculty of Medicine | Medicine | 1-1-2 |
| Year | İH601 | Internal Medicine | Faculty of Medicine | Medicine | 1-1-2 |
| Year | İH601 | Internal Medicine | Faculty of Medicine | Medicine | 1-1-2 |
| Year | İH601 | Internal Medicine | Faculty of Medicine | Medicine | 1-1-2 |
| Year | İH601 | Internal Medicine | Faculty of Medicine | Medicine | 1-1-2 |
| Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
| Year | İH601 | Internal Medicine | Faculty of Medicine | Medicine | 1-1-2 |
| Year | İH601 | Internal Medicine | Faculty of Medicine | Medicine | 1-1-2 |
| Year | İH601 | Internal Medicine | Faculty of Medicine | Medicine | 1-1-2 |
| Year | İH601 | Internal Medicine | Faculty of Medicine | Medicine | 1-1-2 |
